International Journal of Obstetric Anesthesia
Volume 16, Issue 3 , Pages 231-235 , July 2007

Epidural analgesia for parturients with type 1 von Willebrand disease

  • D. Marrache
    • ,
  • F.J. Mercier

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. Frédéric Mercier, M.D., Ph.D., Professor of Anesthesia and Intensive Care, Département d’Anesthésie-Réanimation, Hôpital Antoine Béclère – APHP, 157 rue de la porte de Trivaux, 92141 Clamart cedex, France. Tel.: +00 33 01 45 37 42 73; fax: +00 33 01 45 37 49 85.
    • ,
  • C. Boyer-Neumann
    • ,
  • S. Roger-Christoph
    • ,
  • D. Benhamou

,Accepted 13 February 2007.

References 

  1. Mannucci PM. Treatment of von Willebrand’s Disease. N Engl J Med. 2004;351:683–694
  2. Federici AB, Castaman G, Mannucci PM Italian Association of Hemophilia Centers (AICE). Guidelines for the diagnosis and the management of von Willebrand disease in Italy. Haemophilia. 2002;8:607–621
  3. Budde U, Drewke E, Mainusch K, Schneppenheim R. Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost. 2002;28:173–190
  4. Chediak JR, Alban GM, Maxey B. Von Willebrand’s disease and pregnancy: Management during delivery and outcome of offspring. Am J Obstet Gynecol. 1986;155:618–624
  5. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand’s disease or factor XI deficiency. Br J Obstet Gynaecol. 1998;105:314–321
  6. Cohen S, Daitch JS, Amar D, Goldiner PL. Epidural analgesia for labor and delivery in a patient with von Willebrand’s disease. Reg Anesth. 1989;14:95–97
  7. Milaskiewicz RM, Holdcroft A, Letsky E. Epidural anaesthesia and Von Willebrand’s disease. Anaesthesia. 1990;45:462–464
  8. Suddeth BH, Schmalenberger KP, Mandell GL, Golebiewsky KA. Von Willebrand’s disease and regional anesthesia in the parturient. Anesthesiology. 2003;98(Supp 1):A57
  9. Fressinaud E, Veyradier A, Sigaud M, Boyer-Neumann C, Le Boterff C, Meyer D. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates. Br J Haematol. 1999;106:777–783
  10. Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von Willebrand disease with a new analyser using high shear stress: A study of 60 cases. Blood. 1998;91:1325–1331
  11. Dimitriadou C, Sultan Y, Levy-Toledano S, Bernal-Hoyos JE, Caen J. Quantitative study of bleeding time and platelet function during thrombopenic purpura. Nouv Presse Med. 1974;3:1425–1428
  12. Miller CH, Haff E, Platt SJ, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost. 2003;1:2191–2197
  13. Sadler JE. Slippery criteria for von Willebrand disease type 1. J Thromb Haemost. 2004;2:1720–1723
  14. Wuillemin WA, Gasser KM, Zeeleder SS, Lammle B. Evaluation of a platelet function analyser (PFA-100®) in patients with a bleeding tendency. Swiss Med Wkly. 2002;132:443–448
  15. Ortel TL, James AH, Thames EH, Moore KD, Greenberg CS. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center. Thromb Haemost. 2000;84:93–97
  16. Vincelot A, Nathan N, Collet D, Mehaddi Y, Granchamp P, Julia A. Platelet function during pregnancy: an evaluation using the PFA-100 analyser. Br J Anaesth. 2001;87:890–893
  17. Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost. 1998;24:195–202
  18. Cattaneo M, Federici AB, Lecchi A, et al. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thromb Haemost. 1999;82:35–39
  19. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg. 2003;96:51–57
  20. Fattorutto M, Pradier O, Schmartz D, Ickx B, Barvais L. Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass?. Br J Anaesth. 2003;90:692–693
  21. Quiroga T, Goycoolea M, Munoz B, et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost. 2004;2:890–891

 Presented in oral communication at the annual meeting of the French Society of Anesthesiology and Intensive Care (SFAR), Paris, September 19, 2003 and the joint French-British meeting of obstetric anaesthesia (CARO-OAA), Versailles, April 16, 2004.

PII: S0959-289X(07)00053-2

doi: 10.1016/j.ijoa.2007.02.013

International Journal of Obstetric Anesthesia
Volume 16, Issue 3 , Pages 231-235 , July 2007

Article Tools

* Image Usage & Resolution